3D printing offers hope of building human organs from scratch. Replacement skin, livers and bladders on horizon etc.
The global market for 3D Printed Organs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for 3D Printed Organs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for 3D Printed Organs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for 3D Printed Organs was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of 3D Printed Organs include CELLINK, Organovo, Aspect Biosystems, Cyfuse Biomedical, TeVido Biodevices, Digilab, Advanced Solutions Life Sciences, nScrypt and EnvisionTEC, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for 3D Printed Organs, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of 3D Printed Organs by region & country, by Type, and by Application.
The 3D Printed Organs market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printed Organs.
麻豆原创 Segmentation
By Company
CELLINK
Organovo
Aspect Biosystems
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
nScrypt
EnvisionTEC
MedPrin
3Dynamics Systems Ltd
Segment by Type:
Hydrogel
Living Cells
Segment by Application
Ear
Kidney
Blood Vessel
Skin Graft
Bone
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of 3D Printed Organs manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of 3D Printed Organs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of 3D Printed Organs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 3D Printed Organs Product Introduction
1.2 Global 3D Printed Organs 麻豆原创 Size Forecast
1.3 3D Printed Organs 麻豆原创 Trends & Drivers
1.3.1 3D Printed Organs Industry Trends
1.3.2 3D Printed Organs 麻豆原创 Drivers & Opportunity
1.3.3 3D Printed Organs 麻豆原创 Challenges
1.3.4 3D Printed Organs 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 3D Printed Organs Players Revenue Ranking (2023)
2.2 Global 3D Printed Organs Revenue by Company (2019-2024)
2.3 Key Companies 3D Printed Organs Manufacturing Base Distribution and Headquarters
2.4 Key Companies 3D Printed Organs Product Offered
2.5 Key Companies Time to Begin Mass Production of 3D Printed Organs
2.6 3D Printed Organs 麻豆原创 Competitive Analysis
2.6.1 3D Printed Organs 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by 3D Printed Organs Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printed Organs as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hydrogel
3.1.2 Living Cells
3.2 Global 3D Printed Organs Sales Value by Type
3.2.1 Global 3D Printed Organs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global 3D Printed Organs Sales Value, by Type (2019-2030)
3.2.3 Global 3D Printed Organs Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ear
4.1.2 Kidney
4.1.3 Blood Vessel
4.1.4 Skin Graft
4.1.5 Bone
4.1.6 Others
4.2 Global 3D Printed Organs Sales Value by Application
4.2.1 Global 3D Printed Organs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global 3D Printed Organs Sales Value, by Application (2019-2030)
4.2.3 Global 3D Printed Organs Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global 3D Printed Organs Sales Value by Region
5.1.1 Global 3D Printed Organs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global 3D Printed Organs Sales Value by Region (2019-2024)
5.1.3 Global 3D Printed Organs Sales Value by Region (2025-2030)
5.1.4 Global 3D Printed Organs Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America 3D Printed Organs Sales Value, 2019-2030
5.2.2 North America 3D Printed Organs Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe 3D Printed Organs Sales Value, 2019-2030
5.3.2 Europe 3D Printed Organs Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific 3D Printed Organs Sales Value, 2019-2030
5.4.2 Asia Pacific 3D Printed Organs Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America 3D Printed Organs Sales Value, 2019-2030
5.5.2 South America 3D Printed Organs Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa 3D Printed Organs Sales Value, 2019-2030
5.6.2 Middle East & Africa 3D Printed Organs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 3D Printed Organs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions 3D Printed Organs Sales Value
6.3 United States
6.3.1 United States 3D Printed Organs Sales Value, 2019-2030
6.3.2 United States 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States 3D Printed Organs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe 3D Printed Organs Sales Value, 2019-2030
6.4.2 Europe 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe 3D Printed Organs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China 3D Printed Organs Sales Value, 2019-2030
6.5.2 China 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.5.3 China 3D Printed Organs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan 3D Printed Organs Sales Value, 2019-2030
6.6.2 Japan 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan 3D Printed Organs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea 3D Printed Organs Sales Value, 2019-2030
6.7.2 South Korea 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea 3D Printed Organs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia 3D Printed Organs Sales Value, 2019-2030
6.8.2 Southeast Asia 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia 3D Printed Organs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India 3D Printed Organs Sales Value, 2019-2030
6.9.2 India 3D Printed Organs Sales Value by Type (%), 2023 VS 2030
6.9.3 India 3D Printed Organs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CELLINK
7.1.1 CELLINK Profile
7.1.2 CELLINK Main Business
7.1.3 CELLINK 3D Printed Organs Products, Services and Solutions
7.1.4 CELLINK 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.1.5 CELLINK Recent Developments
7.2 Organovo
7.2.1 Organovo Profile
7.2.2 Organovo Main Business
7.2.3 Organovo 3D Printed Organs Products, Services and Solutions
7.2.4 Organovo 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.2.5 Organovo Recent Developments
7.3 Aspect Biosystems
7.3.1 Aspect Biosystems Profile
7.3.2 Aspect Biosystems Main Business
7.3.3 Aspect Biosystems 3D Printed Organs Products, Services and Solutions
7.3.4 Aspect Biosystems 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.3.5 Cyfuse Biomedical Recent Developments
7.4 Cyfuse Biomedical
7.4.1 Cyfuse Biomedical Profile
7.4.2 Cyfuse Biomedical Main Business
7.4.3 Cyfuse Biomedical 3D Printed Organs Products, Services and Solutions
7.4.4 Cyfuse Biomedical 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.4.5 Cyfuse Biomedical Recent Developments
7.5 TeVido Biodevices
7.5.1 TeVido Biodevices Profile
7.5.2 TeVido Biodevices Main Business
7.5.3 TeVido Biodevices 3D Printed Organs Products, Services and Solutions
7.5.4 TeVido Biodevices 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.5.5 TeVido Biodevices Recent Developments
7.6 Digilab
7.6.1 Digilab Profile
7.6.2 Digilab Main Business
7.6.3 Digilab 3D Printed Organs Products, Services and Solutions
7.6.4 Digilab 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.6.5 Digilab Recent Developments
7.7 Advanced Solutions Life Sciences
7.7.1 Advanced Solutions Life Sciences Profile
7.7.2 Advanced Solutions Life Sciences Main Business
7.7.3 Advanced Solutions Life Sciences 3D Printed Organs Products, Services and Solutions
7.7.4 Advanced Solutions Life Sciences 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.7.5 Advanced Solutions Life Sciences Recent Developments
7.8 nScrypt
7.8.1 nScrypt Profile
7.8.2 nScrypt Main Business
7.8.3 nScrypt 3D Printed Organs Products, Services and Solutions
7.8.4 nScrypt 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.8.5 nScrypt Recent Developments
7.9 EnvisionTEC
7.9.1 EnvisionTEC Profile
7.9.2 EnvisionTEC Main Business
7.9.3 EnvisionTEC 3D Printed Organs Products, Services and Solutions
7.9.4 EnvisionTEC 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.9.5 EnvisionTEC Recent Developments
7.10 MedPrin
7.10.1 MedPrin Profile
7.10.2 MedPrin Main Business
7.10.3 MedPrin 3D Printed Organs Products, Services and Solutions
7.10.4 MedPrin 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.10.5 MedPrin Recent Developments
7.11 3Dynamics Systems Ltd
7.11.1 3Dynamics Systems Ltd Profile
7.11.2 3Dynamics Systems Ltd Main Business
7.11.3 3Dynamics Systems Ltd 3D Printed Organs Products, Services and Solutions
7.11.4 3Dynamics Systems Ltd 3D Printed Organs Revenue (US$ Million) & (2019-2024)
7.11.5 3Dynamics Systems Ltd Recent Developments
8 Industry Chain Analysis
8.1 3D Printed Organs Industrial Chain
8.2 3D Printed Organs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 3D Printed Organs Sales Model
8.5.2 Sales Channel
8.5.3 3D Printed Organs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
CELLINK
Organovo
Aspect Biosystems
Cyfuse Biomedical
TeVido Biodevices
Digilab
Advanced Solutions Life Sciences
nScrypt
EnvisionTEC
MedPrin
3Dynamics Systems Ltd
听
听
*If Applicable.